Preoperative use of erythropoietin (rH-EPO) and determination of optimal doses in patients with benign prostatic hypertrophy for future autologous blood transfusion

• Published in: Nippon Hinyokika Gakkai zasshi Vol. 86; no. 12; p. 1720
• Main Author: Inatsuchi, H
• Format: Journal Article
• Language: Japanese
• Published: Japan 01.12.1995
• Subjects: Aged; Blood Transfusion, Autologous - methods; Erythropoietin - administration & dosage; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Preoperative Care; Prostatectomy; Prostatic Hyperplasia - surgery; Prostatic Hyperplasia - therapy; Recombinant Proteins - administration & dosage

Recently, autologous blood transfusion has been widely endorsed, because of the adverse effects attributed to homologous blood transfusion. We found that the administration of recombinant human erythropoietin (rH-EPO) permitted the preoperative collection of an adequate volume of autologous blood in...